# Metastatic Solid Cancer Clinical Trial

> **NCT04739618** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **ImmunSYS, LLC** · enrollment: 32 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

- **DRUG:** Keytruda Injectable Product
- **DRUG:** Yervoy Injectable Product
- **DRUG:** GM-CSF
- **PROCEDURE:** Non-ablative Cryosurgical freezing

## Key facts

- **NCT ID:** NCT04739618
- **Lead sponsor:** ImmunSYS, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-04
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04739618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04739618, "Metastatic Solid Cancer Clinical Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04739618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*